Elastrin Therapeutics

Biotechnology
$10.8Mtotal raised · 5 rounds on record
$4.8Mlatest round · Venture round · Oct 2023 · 3 yr ago
1backers · SCRA
2018founded

Overview

Elastrin Therapeutics develops antibody-targeted nanoparticle therapies that reverse arterial calcification. Treating the cause, not the symptoms.

Funding and backers

Total raised
$10.8M
5 rounds on record
Latest round
$4.8M
Venture round · Oct 2023 · 3 yr ago
Backers
1
SCRA
The money's age
Long since its last round
36 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 11, 2024 Took on debt financing $500k · SEC Form D Oct 25, 2023 Raised a round Venture round $4.8M · SEC Form D Aug 11, 2023 Took on debt financing $2M · SEC Form D Mar 23, 2022 Raised a round Venture round $3.6M · SEC Form D Feb 17, 2021 Raised a round Venture round $2.5M · SEC Form D 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Sep 2024 $500k — SEC Form D
Venture round Oct 2023 $4.8M — SEC Form D
Debt Financing Aug 2023 $2M — SEC Form D
Venture round Mar 2022 $3.6M — SEC Form D
Venture round Feb 2021 $2.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Elastrin Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Naren VyavahareExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
SCRA fund
Investors in similar startupsfunds that back the companies most like this one
RA Capital Management
backs Genmab
Oxford Technology
backs NikaLyte
Sofinnova Investments
backs Genmab
LAV
backs Genmab
Newfund
backs Inside Therapeutics
Nextech Invest
backs Genmab
Similar startupsby what they do, their industry and backers
GenmabFounded 1999 · 2 roles
Genmab is an international biotechnology company, founded in 1999, that develops antibody products and antibody medicines, primarily for…
Inside TherapeuticsFounded 2023 · 11-50 employees
Inside Therapeutics is a company specialized in providing system for nanoparticle synthesis or nanoparticle manufacturing using…
AbbratechVenture round $8.5M · 2 yr ago · Founded 2023 · 51-200 employees
A Novel Platform for Antibody Discovery, Engineering and Validation. Antibody therapies are an increasingly important tool for treating…
NikaLyteFounded 2019 · 1-10 employees
Nikalyte are nanoparticle technology experts who specialise in nanoparticle deposition systems. Learn about vacuum operated systems and…
SoFab InksVenture round $2.9M · 5 mo ago · Founded 2024 · 11-50 employees
Sofab develops and manufactures innovative nanoparticles with a core focus on solar perovskite solutions.
Flo Axiom
Sub-micron affinity nanoparticles, grown inside engineered bacteria. The next generation of antibody purification.

Financials

Total raised
$13.3M
Latest round
Debt Financing
Funding rounds
5
Funding rounds
Round Announced Amount
Debt Financing 2024 $500k Details
Venture - Series Unknown 2023 $4.8M Details
Debt Financing 2023 $2M Details
Venture - Series Unknown 2022 $3.6M Details
Venture - Series Unknown 2021 $2.5M Details

People

Naren Vyavahare
Executive Officer, Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
SCRAVia a fund
67 portfolio companies: Zipitwireless, Zylö Therapeutics >>, ZVerse, Inc. and 64 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Greenville United States
HQ
Engage with Us
Elastrin Therapeutics Inc. 200 C, Patewood Drive Greenville, South Carolina 29615 USA
company site